ONCOPRECISION
We're developing technologies to replicate cancer patients' disease ex-vivo to rapidly and accurately test a broad range of treatments simultaneously to help oncologists provide the most suitable treatment for each patient and pharmaceutical companies develop transformational therapies.
ONCOPRECISION
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2020-09-25
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.oncoprecision.bio
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
4.16 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Google Universal Analytics Apache Mobile Non Scaleable Content Google Apps For Business AJAX Libraries API
Similar Organizations
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Advisors List
Current Employees Featured
Founder
Investors List
New York State’s Empire State Development Fund
New York State’s Empire State Development Fund investment in Seed Round - OncoPrecision
Martin Anazco
Martin Anazco investment in Seed Round - OncoPrecision
Creative Ventures
Creative Ventures investment in Seed Round - OncoPrecision
GRID EXPONENTIAL
GRID EXPONENTIAL investment in Seed Round - OncoPrecision
IndieBio
IndieBio investment in Seed Round - OncoPrecision
Diego Meller
Diego Meller investment in Seed Round - OncoPrecision
SOSV
SOSV investment in Seed Round - OncoPrecision
SOSV
SOSV investment in Pre Seed Round - OncoPrecision
GRID EXPONENTIAL
GRID EXPONENTIAL investment in Pre Seed Round - OncoPrecision
Official Site Inspections
http://www.oncoprecision.bio Semrush global rank: 4.39 M Semrush visits lastest month: 2.55 K
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "OncoPrecision"
OncoPrecision
2024© OncoPrecision Corporation all rights reserved. 180 Varick St, 6th Floor, New York, NY, 10014See details»
OncoPrecision - Crunchbase Company Profile & Funding
OncoPrecision closed its last funding round on Jun 20, 2024 from a Convertible Note round. Who are OncoPrecision 's competitors? Alternatives and possible competitors to OncoPrecision may include Aro Biotherapeutics , Tmunity …See details»
OncoPrecision - LinkedIn
OncoPrecision | 3,927 followers on LinkedIn. Leveraging single-cell high-throughput biology and AI/ML to dramatically increase the success of cancer therapy. | Leveraging single-cell high ...See details»
OncoPrecision Company Profile 2024: Valuation, Funding
OncoPrecision General Information Description. Developer of a patient micro avatar platform designed to get the right cancer therapy to the right patient. The company's platform leverages …See details»
Battling cancer: How OncoPrecision is using AI to …
Oct 30, 2022 Battling cancer: How OncoPrecision is using AI to change the game. After raising $4.2m in pre-seed and seed funding, the Argentina-based biotech start-up is aiming to offer its diagnostics services to cancer clinics by …See details»
OncoPrecision - IndieBio - #1 in Early Stage Biotech
Their unique, triple co-culture method increases patient-derived cancer cell viability 60x in a 2.5D format that has been validated using real patient data. For patients in dire need of the right cancer treatment the first time, OncoPrecision …See details»
OncoPrecision Raises $3.3M Seed Funding to Improve …
Oct 31, 2022 OncoPrecision was born as an idea that originated while Dr. Soria was leading his Synthetic Lethality Lab at the National University of Córdoba after returning from his Postdoctoral Studies in ...See details»
OncoPrecision Company Profile - Office Locations, Competitors
OncoPrecision is a biotech company developing technologies for the treatment of oncology diseases. It provides a platform that focuses on obtaining cells from biopsies and recreating …See details»
IndieBio’s OncoPrecision closes $3.3M seed round to …
OncoPrecision creates functional assays for individual cancer patients to help oncologists determine a personalized and effective medication plan. With this most recent funding round, OncoPrecision plans to develop Patient Micro …See details»
OncoPrecision Raises $3.3M for Its Patient Micro …
Oct 31, 2022 OncoPrecision has raised a total of $4.2 million to date. The company’s high-throughput platform focuses on obtaining patient-derived cells from biopsies and recreating the tumor microenvironment by combining them …See details»
Gastón Soria - Co-Founder & Chief Scientific Officer
Co-Founder & Chief Scientific Officer at OncoPrecision · At OncoPrecision, our mission is conceptually simple yet scientifically challenging: developing a phenotypic screening engine with patient ...See details»
OncoPrecision - SOSV
Oncoprecision.bio . Team Tarek Ali Zaki. Co-Founder & CEO. Gastón Soria. Co-Founder & CSO. Candelaria Llorens de los Ríos. Co-Founder & Director of Lab Operations. Gerardo Gatti. Co …See details»
OncoPrecision - Products, Competitors, Financials, Employees ...
OncoPrecision Raises $3.3M Seed Funding to Improve Cancer Patient Outcomes and Drug Development Efforts with “Patient Micro Avatars” NEW YORK, October 31, 2022-- Today …See details»
OncoPrecision - Company Profile & Staff Directory - ContactOut
We're developing technologies to replicate cancer patients' disease ex-vivo to rapidly and accurately test a broad range of treatments simultaneously to help oncologists provide the …See details»
OncoPrecision - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jun 20, 2024: ... Seed Round - …See details»
OncoPrecision - GRIDX
Democratizing access to Precision Oncology. What's the Problem?. The development of novel cancer therapies is currently governed by a patient-last paradigm, which relies on preclinical …See details»
OncoPrecision Raises $3.3M Seed Funding - citybiz
Oct 31, 2022 NEW YORK–(BUSINESS WIRE)–Today OncoPrecision announces $3.3 million in Seed Funding to further develop its Patient Micro Avatar technology which seeks to recreate …See details»
OncoPrecision: A matter of life and death - cancer avatars …
OncoPrecision can predict a patient’s response to cancer therapies by replicating the tumor microenvironment ex vivo. Their unique, triple co-culture method increases patient-derived …See details»
OncoPrecision Validating Patient-Derived Functional Drug …
Nov 1, 2022 OncoPrecision's technology involves what OncoPrecision has dubbed Patient Micro Avatars. The avatars, derived from patients' tumor cells and combined with OncoPrecision's …See details»
OncoPrecision - CEO and Investor Conference 2025 - bcic.bio.org
February 10-11, 2025・New York, NY. Home; About. Event Overview; 2024 Schedule at a Glance; 2024 Event Preview WebinarSee details»